The metabolic load-capacity model and cardiometabolic health in children and youth with obesity

Pediatr Obes. 2024 Mar;19(3):e13098. doi: 10.1111/ijpo.13098. Epub 2024 Jan 23.

Abstract

Background: The metabolic load-capacity index (LCI), which represents the ratio of adipose to skeletal muscle tissue-containing compartments, is potentially associated with cardiometabolic diseases.

Objectives: To examine the associations between the LCI and cardiometabolic risk factors in children and youth with obesity.

Methods: This is a cross-sectional study including 10-18 years-old participants with a BMI of ≥95th . LCI by air-displacement plethysmography (ADP) was calculated as fat mass divided by fat-free mass, and LCI by ultrasound (US) as subcutaneous adipose tissue divided by skeletal muscle thickness. Sex-specific medians stratified participants into high versus low LCI. Single (inflammation, insulin resistance, dyslipidemia and hypertension) and clustered cardiometabolic risk factors were evaluated. Linear and logistic regression models tested the associations between these variables, adjusted for sexual maturation.

Results: Thirty-nine participants (43.6% males; 59% mid-late puberty) aged 12.5 (IQR: 11.1-13.5) years were included. LCI by ADP was positively associated with markers of inflammation and dyslipidemia; having a higher LCI predicted dyslipidemia in logistic regression. Similarly, LCI by US was positively associated with markers of dyslipidemia and blood pressure. In mid-late pubertal participants, LCI by US was positively associated with markers of insulin resistance and inflammation.

Conclusions: Participants with unfavourable cardiometabolic profile had higher LCI, suggesting its potential use for predicting and monitoring cardiometabolic health in clinical settings.

Keywords: body composition; cardiometabolic health; fat mass; muscle mass; pediatric obesity.

MeSH terms

  • Adolescent
  • Body Mass Index
  • Cardiovascular Diseases* / etiology
  • Child
  • Cross-Sectional Studies
  • Dyslipidemias* / complications
  • Dyslipidemias* / epidemiology
  • Female
  • Humans
  • Inflammation / complications
  • Insulin Resistance*
  • Male
  • Obesity / complications
  • Obesity / epidemiology
  • Risk Factors